Literature DB >> 22251767

Food and Drug Administration evaluation and cigarette smoking risk perceptions.

Annette R Kaufman1, Erika A Waters, Mark Parascandola, Erik M Augustson, Maansi Bansal-Travers, Andrew Hyland, K Michael Cummings.   

Abstract

OBJECTIVES: To examine the relationship between a belief about Food and Drug Administration (FDA) safety evaluation of cigarettes and smoking risk perceptions.
METHODS: A nationally representative, random-digit-dialed telephone survey of 1046 adult current cigarette smokers.
RESULTS: Smokers reporting that the FDA does not evaluate cigarettes for safety (46.1%), exhibited greater comprehension of the health risks of smoking and were more likely (48.5%) than other participants (33.6%) to report quit intentions. Risk perceptions partially mediated the relationship between FDA evaluation belief and quit intentions.
CONCLUSIONS: These findings highlight the need for proactive, effective communication to the public about the aims of new tobacco product regulations.

Entities:  

Mesh:

Year:  2011        PMID: 22251767      PMCID: PMC3755771          DOI: 10.5993/ajhb.35.6.12

Source DB:  PubMed          Journal:  Am J Health Behav        ISSN: 1087-3244


  16 in total

1.  Do "Light" cigarettes undermine cessation?

Authors:  J R Hughes
Journal:  Tob Control       Date:  2001       Impact factor: 7.552

2.  Smokers' unrealistic optimism about their risk.

Authors:  N D Weinstein; S E Marcus; R P Moser
Journal:  Tob Control       Date:  2005-02       Impact factor: 7.552

3.  Accuracy and optimism in smokers' beliefs about quitting.

Authors:  Neil D Weinstein; Paul Slovic; Ginger Gibson
Journal:  Nicotine Tob Res       Date:  2004-12       Impact factor: 4.244

4.  Smokers' responses to advertisements for regular and light cigarettes and potential reduced-exposure tobacco products.

Authors:  William L Hamilton; Giulia diStefano Norton; Tammy K Ouellette; Wiliam M Rhodes; Ryan Kling; Gregory N Connolly
Journal:  Nicotine Tob Res       Date:  2004-12       Impact factor: 4.244

5.  Are smokers adequately informed about the health risks of smoking and medicinal nicotine?

Authors:  K Michael Cummings; Andrew Hyland; Gary A Giovino; Janice L Hastrup; Joseph E Bauer; Maansi A Bansal
Journal:  Nicotine Tob Res       Date:  2004-12       Impact factor: 4.244

6.  College students' expectancies for light cigarettes and potential reduced exposure products.

Authors:  Richard J O'Connor; Rebecca L Ashare; Brian V Fix; Larry W Hawk; K Michael Cummings; William C Schmidt
Journal:  Am J Health Behav       Date:  2007 Jul-Aug

7.  The proposed tobacco regulation: the triumph of hope over experience?

Authors:  Lynn T Kozlowski
Journal:  Tob Control       Date:  2008-04       Impact factor: 7.552

8.  Benefits and risks in ending regulatory exceptionalism for tobacco.

Authors:  Simon Chapman
Journal:  Tob Control       Date:  2008-04       Impact factor: 7.552

9.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations.

Authors:  R M Baron; D A Kenny
Journal:  J Pers Soc Psychol       Date:  1986-12

10.  What makes consumers think dietary supplements are safe and effective? The role of disclaimers and FDA approval.

Authors:  Tonya Dodge; Annette Kaufman
Journal:  Health Psychol       Date:  2007-07       Impact factor: 4.267

View more
  9 in total

1.  Food and Drug Administration tobacco regulation and product judgments.

Authors:  Annette R Kaufman; Lila J Finney Rutten; Mark Parascandola; Kelly D Blake; Erik M Augustson
Journal:  Am J Prev Med       Date:  2015-02-25       Impact factor: 5.043

2.  U.S. adult perceptions of the harmfulness of tobacco products: descriptive findings from the 2013-14 baseline wave 1 of the path study.

Authors:  Geoffrey T Fong; Tara Elton-Marshall; Pete Driezen; Annette R Kaufman; K Michael Cummings; Kelvin Choi; Jonathan Kwan; Amber Koblitz; Andrew Hyland; Maansi Bansal-Travers; Charles Carusi; Mary E Thompson
Journal:  Addict Behav       Date:  2018-11-17       Impact factor: 3.913

3.  Knowledge About E-Cigarette Constituents and Regulation: Results From a National Survey of U.S. Young Adults.

Authors:  Ashley N Sanders-Jackson; Andy S L Tan; Cabral A Bigman; Lisa Henriksen
Journal:  Nicotine Tob Res       Date:  2014-12-26       Impact factor: 4.244

4.  Smokers' attitudes and support for e-cigarette policies and regulation in the USA.

Authors:  Olivia A Wackowski; Cristine D Delnevo
Journal:  Tob Control       Date:  2015-01-06       Impact factor: 7.552

5.  Knowledge about Chemicals in e-Cigarette Secondhand Vapor and Perceived Harms of Exposure among a National Sample of U.S. Adults.

Authors:  Andy S L Tan; Susan Mello; Ashley Sanders-Jackson; Cabral A Bigman
Journal:  Risk Anal       Date:  2016-09-05       Impact factor: 4.000

6.  Beliefs about FDA tobacco regulation, modifiability of cancer risk, and tobacco product comparative harm perceptions: Findings from the HINTS-FDA 2015.

Authors:  Anh B Nguyen; James Henrie; Wendy I Slavit; Annette R Kaufman
Journal:  Prev Med       Date:  2018-01-31       Impact factor: 4.018

7.  Public Knowledge and Credibility Perceptions of the FDA as a Tobacco Regulator.

Authors:  Allison M Schmidt; Kristen L Jarman; Leah M Ranney; Tara L Queen; Seth M Noar; Laura Ruel; Robert Agans; Anika Hannan; Adam O Goldstein
Journal:  Nicotine Tob Res       Date:  2018-09-25       Impact factor: 4.244

8.  Effects of Framing Proximal Benefits of Quitting and Motivation to Quit as a Query on Communications About Tobacco Constituents.

Authors:  Sarah Kowitt; Paschal Sheeran; Kristen Jarman; Leah M Ranney; Allison M Schmidt; Li-Ling Huang; Adam O Goldstein
Journal:  Nicotine Tob Res       Date:  2017-10-01       Impact factor: 4.244

9.  To Regulate or Not to Regulate? Views on Electronic Cigarette Regulations and Beliefs about the Reasons for and against Regulation.

Authors:  Ashley Sanders-Jackson; Andy S L Tan; Cabral A Bigman; Susan Mello; Jeff Niederdeppe
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.